The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Influenza-Associated Pediatric Mortality in the United States: Increase of Staphylococcus aureus Coinfection
Abstract
OBJECTIVE: Pediatric influenza-associated death became a nationally notifiable condition in the United States during 2004. We describe influenza-associated pediatric mortality from 2004 to 2007, including an increase of Staphylococcus aureus coinfections. METHODS: Influenza-associated pediatric death is defined as a death of a child who is younger than 18 years and has laboratory-confirmed influenza. State and local health departments report to the Centers for Disease Control and Prevention demographic, clinical, and laboratory data on influenza-associated pediatric deaths. RESULTS: During the 2004-2007 influenza seasons, 166 influenza-associated pediatric deaths were reported (n = 47, 46, and 73, respectively). Median age of the children was 5 years. Children often progressed rapidly to death; 45% died within 72 hours of onset, including 43% who died at home or in an emergency department. Of 90 children who were recommended for influenza vaccination, only 5 (6%) were fully vaccinated. Reports of bacterial coinfection increased substantially from 2004-2005 to 2006-2007 (6%, 15%, and 34%, respectively). S aureus was isolated from a sterile site or endotracheal tube culture in 1 case in 2004-2005, 3 cases in 2005-2006, and 22 cases in 2006-2007; 64% were methicillin-resistant S aureus. Children with S aureus coinfection were significantly older and more likely to have pneumonia and acute respiratory distress syndrome than those who were not coinfected. CONCLUSIONS: Influenza-associated pediatric mortality is rare, but the proportion of S aureus coinfection identified increased fivefold over the past 3 seasons. Research is needed to identify risk factors for influenza coinfection with invasive bacteria and to determine the impact of influenza vaccination and antiviral agents in preventing pediatric mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Influenza B, although generally regarded as having less impact on morbidity and mortality in healthy persons can also cause severe secondary bacterial infection during seasonal influenza episodes, especially within younger age groups.”
From Bacterial and viral infections associated with influenza (2013) · cites this paper as [5]
In the citing paper
“deaths, especially in children are also associated with S aureus infection, as highlighted by the recent emergence of community‐acquired methicillin‐resistant Staphylococcus aureus (MRSA)”
From Bacterial and viral infections associated with influenza (2013) · cites this paper as [5]
In the citing paper
“Streptococcus pneumoniae continues to be the dominant pathogen involved in this synergistic process7 followed mainly by Staphylococcus aureus 5 and Haemophilus influenzae.12, 18”
From Bacterial and viral infections associated with influenza (2013) · cites this paper as [5]
In the citing paper
“with evidence that community‐acquired MRSA infections are leading to high levels of morbidity and mortality in individuals with influenza, especially children.5”
From Bacterial and viral infections associated with influenza (2013) · cites this paper as [5]
In the citing paper
“Although reported less, influenza B has also been associated with severe bacterial co/secondary infection (Finelli et al., 2008; Aebi et al., 2010).”
From Secondary bacterial infections associated with influenza pandemics (2017) · cites this paper as Finelli et al., 2008
In the citing paper
“The disease is characterized as fulminant, with short intervals between onset of illness and diagnosis of pneumonia (,7 days) and rapid (often within ,24 h) progression to severe disease with multilobar involvement [6,7,9,11,12].”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [11]
In the citing paper
“These strains are now frequently being identified as agents of bacterial pneumonia, particularly in children with influenza [10,11].”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [11]
In the citing paper
“In studies examining severe or fatal cases, however, the pathogenesis of influenza-associated S. aureus pneumonia seems to be distinct from that of typical community-acquired pneumonia.”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [11]
In the citing paper
“the recently emerged USA300 and USA400 clones that have been linked to a surge in necrotizing pneumonia in patients with influenza [9-11, 15, 29-31] act synergistically with influenza virus.”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [11]
In the citing paper
“Influenza-staphylococcal coinfections have increased following the emergence of the USA300 and USA400 lineages [9,11,30,31], and S. aureus has been identified as a common cause of death during the recent H1N1 influenza pandemic [12,15].”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [11]
In the citing paper
“This likely explains the changed epidemiological character that has been observed during the past decade, as S. aureus coinfections with influenza have become more common [10,11,47].”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [11]
Citations
Cites
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Self-citationMethicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055356 · Cited by 2,285
Self-citationInfluenza-Associated Hospitalizations in the United States
Thompson, W. W. (2004) · JAMA · doi:10.1001/jama.292.11.1333 · Cited by 2,213
Le, M. (2007) · Medical Entomology and Zoology · Cited by 1,624
Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza
Treanor, J. J., Hayden, F. G., Vrooman, P., Barbarash, R. A., Bettis, R. B., Riff, D. S., Singh, S., Kinnersley, N., Ward, P., Mills, R., et al. (2000) · JAMA · doi:10.1001/jama.283.8.1016 · Cited by 1,019
Influenza and the Rates of Hospitalization for Respiratory Disease among Infants and Young Children
Izurieta, H. S., Thompson, W., Kramarz, P., Shay, D. K., Davis, R. L., Destefano, F. R., BLACK, S. B., Shinefield, H. R., & Fukuda, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001273420402 · Cited by 1,013
Self-citationGorwitz, R. J., Kruszon‐Moran, D., McAllister, S. K., McQuillan, G. M., McDougal, L. K., Fosheim, G. E., Jensen, B. J., Killgore, G., Tenover, F. C., & Kuehnert, M. J. (2008) · The Journal of Infectious Diseases · doi:10.1086/533494 · Cited by 949
Self-citationInsights into the Interaction between Influenza Virus and Pneumococcus
McCullers, J. A. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-05 · Cited by 846
King, M. D., Humphrey, B. J., Wang, Y. F., Kourbatova, E. V., Ray, S. M., & Blumberg, H. M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00005 · Cited by 776
Oral oseltamivir treatment of influenza in children
WHITLEY, R. J., HAYDEN, F. G., REISINGER, K. S., YOUNG, N., DUTKOWSKI, R., IPE, D., MILLS, R. G., & WARD, P. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200102000-00002 · Cited by 711
Research works printed but not linked: 2
- Jakab GJ. Immune impairment of alveolar macrophage phagocytosis during influenza virus pneumonia. Am Rev Respir Dis. 1982;126(5):778–782
- Adam H, McGeer A, Simor A. Fatal case of post-influenza, community-associated MRSA pneumonia in an Ontario teenager with subsequent familial transmission. Can Commun Dis Rep. 2007;33(4):45–48
Cited by
Sorted by citations
Items 101–200 of 312
Influenza Coinfection and Outcomes in Children With Complicated Pneumonia
Williams, D. J., Hall, M., Brogan, T. V., Farris, R. W. D., Myers, A., Newland, J. G., & Shah, S. S. (2011) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpediatrics.2010.295 · Cited by 57
Jia, L., Zhao, J., Yang, C., Liang, Y., Long, P., Liu, X., Qiu, S., Wang, L., Xie, J., Li, H., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03189 · Cited by 55
Bacterial Coinfections Increase Mortality of Severely Ill COVID-19 Patients in Saudi Arabia
Alqahtani, A., Alamer, E., Mir, M. A., Alasmari, A., Alshahrani, M. M., Asiri, M., Ahmad, I. S., Alhazmi, A., & Algaissi, A. A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19042424 · Cited by 57
Clinical characteristics of children and adults hospitalized for influenza virus infection
Leung, C.-H., Tseng, H.-K., Wang, W., Chiang, H.-T., Wu, A. Y.-J., & Liu, C.-P. (2013) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2013.06.002 · Cited by 56
Severe influenza in children: incidence and risk factors
Principi, N., & Esposito, S. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1227701 · Cited by 56
Nguyen, T., Kyle, U. G., Jaimon, N., Tcharmtchi, M. H., Coss-Bu, J. A., Lam, F., Teruya, J., & Loftis, L. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318260c7f8 · Cited by 54
Humanized Mouse Models of Staphylococcus aureus Infection
Parker, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00512 · Cited by 52
Randolph, A. G., Xu, R., Novak, T., Newhams, M. M., Wardenburg, J. B., Weiss, S. L., Sanders, R. C., Thomas, N. J., Hall, M. W., Tarquinio, K. M., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy495 · Cited by 54
Ding, T., Song, T., Zhou, B., Geber, A. B., Ma, Y., Zhang, L., Volk, M., Kapadia, S. N., Jenkins, S. G., Salvatore, M., et al. (2019) · mBio · doi:10.1128/mbio.01296-19 · Cited by 52
Spaeder, M. C., Custer, J. W., Bembea, M. M., Aganga, D. O., Song, X., & Scafidi, S. (2013) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3182720fc7 · Cited by 52
Robinson, K. M., Ramanan, K., Clay, M. E., McHugh, K. J., Rich, H. E. A., & Alcorn, J. F. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.32 · Cited by 51
Wu, X., Wang, Q., Wang, M., Su, X., Xing, Z., Zhang, W., & Shi, Y. P. (2015) · Respiration · doi:10.1159/000369561 · Cited by 49
Invasive Group A Streptococcal Infection Concurrent with 2009 H1N1 Influenza
Jean, C. M., Louie, J. K., Glaser, C. A., Harriman, K. H., Hacker, J. K., Aranki, F., Bancroft, E., Farley, S. M., Ginsberg, M. M., Hernandez, L. B., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/652291 · Cited by 50
Influenza Immunization in Pregnancy
MacDonald, N. E., Riley, L. E., & Steinhoff, M. C. (2009) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181af6ce8 · Cited by 47
IL-22-binding protein exacerbates influenza, bacterial super-infection
Abood, R. N., McHugh, K. J., Rich, H. E. A., Ortiz, M. A., Tobin, J. M., Ramanan, K., Robinson, K. M., Bomberger, J. M., Kolls, J. K., Manni, M. L., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0188-7 · Cited by 51
The Coming Era of Quadrivalent Human Influenza Vaccines
Barr, I., & Jelley, L. (2012) · Drugs · doi:10.2165/11641110-000000000-00000 · Cited by 47
Klemm, C., Bruchhagen, C., van Krüchten, A., Niemann, S., Löffler, B., Peters, G., Ludwig, S., & Ehrhardt, C. (2017) · Scientific Reports · doi:10.1038/srep42473 · Cited by 46
Prognostic factors of severe community-acquired staphylococcal pneumonia in France
Gillet, Y., Tristan, A., Rasigade, J., Saadatian‐Elahi, M., Bouchiat, C., Bes, M., Dumitrescu, O., Leloire, M., Dupieux, C., Laurent, F. J., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.04445-2020 · Cited by 49
Blevins, L. K., Wren, J. T., Holbrook, B. C., Hayward, S. L., Swords, W. E., Parks, G. D., & Alexander‐Miller, M. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400529 · Cited by 44
Gupta, N., Richter, R. P., Robert, S., & Kong, M. Y. F. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00252 · Cited by 48
Eriksson, C. O., Graham, D. A., Uyeki, T. M., & Randolph, A. G. (2012) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e318260114e · Cited by 44
Self-citationDo specific virus–bacteria pairings drive clinical outcomes of pneumonia?
McCullers, J. A. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12093 · Cited by 47
Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System
Crane, M. J., Lee, K. M., FitzGerald, E. S., & Jamieson, A. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01421 · Cited by 44
Esposito, S., Molteni, C. G., Daleno, C., Valzano, A. G., Fossali, E. F., Dalt, L. D., Cecinati, V., Bruzzese, E., Giacchino, R., Giaquinto, C., et al. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-271 · Cited by 42
Hota, B. N., Lyles, R. D., Rim, J., Popovich, K. J., Rice, T., Aroutcheva, A. A., & Weinstein, R. A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir472 · Cited by 41
STAT1 Is Required for Suppression of Type 17 Immunity during Influenza and Bacterial Superinfection
Lee, B., Gopal, R., Manni, M. L., McHugh, K. J., Mandalapu, S., Robinson, K. M., & Alcorn, J. F. (2017) · ImmunoHorizons · doi:10.4049/immunohorizons.1700030 · Cited by 41
Epidemiology of influenza B in Australia: 2001‐2014 influenza seasons
Moa, A., Muscatello, D. J., Turner, R. M., & MacIntyre, C. R. (2016) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12432 · Cited by 38
Community-Acquired Pneumonia in Children
Stuckey-Schrock, K., Hayes, B. L., & George, C. M. (2023) · Pediatric Emergency Care · doi:10.1097/01.pec.0000997584.00841.b8 · Cited by 37
Principi, N., & Esposito, S. (2009) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2009.07.006 · Cited by 36
Verma, A. K., Bauer, C. D., Palani, S., Metzger, D. W., & Sun, K. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100328 · Cited by 36
Wang, M., Cai, F., Wu, X., Wu, T., Su, X., & Shi, Y. P. (2015) · Respirology · doi:10.1111/resp.12472 · Cited by 36
Spaeder, M. C., & Fackler, J. C. (2011) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3182230f6e · Cited by 34
Fiore, A. E., Epperson, S., Perrotta, D. M., Bernstein, H. H., & Neuzil, K. M. (2012) · PEDIATRICS · doi:10.1542/peds.2011-0737c · Cited by 32
Self-citationInfluenza-associated mortality among children - United States: 2007-2008
Peebles, P. J., Dhara, R., Brammer, L., Fry, A. M., & Finelli, L. (2010) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2010.00166.x · Cited by 31
Self-citationThe rational use of influenza vaccines in healthy children and children with underlying conditions
Esposito, S., & Principi, N. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32832a58e4 · Cited by 31
Martínez-Colón, G. J., Warheit-Niemi, H. I., Gurczynski, S. J., Taylor, Q. M., Wilke, C. A., Podsiad, A. B., Crespo, J., Bhan, U., & Moore, B. B. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007560 · Cited by 34
Davis, B. M., Aiello, A. E., Dawid, S. R., Rohani, P., Shrestha, S., & Foxman, B. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr402 · Cited by 31
Influenza-associated mortality in 2009 in four sentinel sites in Bangladesh
Homaira, N., Luby, S. P., Alamgir, A. S. M., Islam, K., Paul, R. C., Abedin, J., Rahman, M. M., Azim, T., Podder, G., Sohel, B. M., et al. (2012) · Bulletin of the World Health Organization · doi:10.2471/blt.11.095653 · Cited by 30
Self-citationLeMessurier, K. S., Iverson, A., Chang, T., Palipane, M., Vogel, P., Rosch, J. W., & Samarasinghe, A. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-55712-8 · Cited by 30
Baloxavir Marboxil 2% Granules in Japanese Children With Influenza
Yokoyama, T., Sakaguchi, H., Ishibashi, T., Shishido, T., Piedra, P. A., Sato, C., Tsuchiya, K., & Uehara, T. (2020) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002748 · Cited by 30
Chung, D. R., & Huh, K. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.999668 · Cited by 31
Kobayashi, S. D., Olsen, R. J., LaCasse, R. A., Safronetz, D., Ashraf, M., Porter, A. R., Braughton, K. R., Feldmann, F., Clifton, D. R., Kash, J. C., et al. (2013) · Virulence · doi:10.4161/viru.26572 · Cited by 29
SHP2 deficiency promotes Staphylococcus aureus pneumonia following influenza infection
Ouyang, W., Liu, C., Pan, Y., Yu, H., Yang, L., Xia, J., & Xu, F. (2019) · Cell Proliferation · doi:10.1111/cpr.12721 · Cited by 28
Radovanovic, M., Petrović, M., Hanna, R. D., Nordstrom, C. W., Calvin, A. D., Barsoum, M. K., Milosavljevic, N., Jevtic, D., Sokanovic, M., & Dumic, I. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9040103 · Cited by 28
The Etiology of Community-Acquired Pneumonia Correlates with Serum Inflammatory Markers in Children
Wrotek, A., Robakiewicz, J., Pawlik, K. K., Rudziński, P., Pilarska, I., Jaroń, A., Imiełowska, A., Jarzębowska, M., Zabłocka, K., & Jackowska, T. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195506 · Cited by 28
Pediatric influenza‐associated myositis – Nebraska, 2001–2007
Buss, B., Shinde, V., Safranek, T. J., & Uyeki, T. M. (2009) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2009.00102.x · Cited by 28
Self-citationStreng, A., Grote, V., & Liese, J. G. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-233 · Cited by 27
Gopal, R., Mendy, A., Marinelli, M. A., Richwalls, L. J., Seger, P. J., Patel, S., McHugh, K. J., Rich, H. E. A., Grousd, J. A., Forno, E., et al. (2019) · Viruses · doi:10.3390/v11060505 · Cited by 27
Nelson, S. S., Mandelaris, J., Ferretti, G. A., Heima, M., Spiekerman, C. F., & Milgrom, P. (2011) · Journal of Public Health Dentistry · doi:10.1111/j.1752-7325.2011.00282.x · Cited by 26
Cohen, L., Hansen, C., Andrew, M. K., McNeil, S., Vanhems, P., Kynčl, J., Díez‐Domingo, J., Zhang, T., Dbaibo, G. S., Laguna-Torres, V. A., et al. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad303 · Cited by 25
Self-citationGuidelines for the management of community-acquired pneumonia in children.
Lee, P., Chiu, C., Chen, P.-Y., Lee, C., & Lin, T. (2007) · PubMed · Cited by 25
Kallen, A. J., Reed, C., PATTON, M., ARNOLD, K. E., Finelli, L., & Hageman, J. C. (2009) · Epidemiology and Infection · doi:10.1017/s095026880999135x · Cited by 25
Self-citationInactivated Influenza Vaccines
Bresee, J., Fry, A. M., Sambhara, S. R., & Cox, N. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00031-6 · Cited by 24
Self-citationStockman, L. J., Reed, C., Kallen, A. J., Finelli, L., & Anderson, L. J. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181eb7315 · Cited by 24
Self-citationMina, M. J., Klugman, K. P., Rosch, J. W., & McCullers, J. A. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu804 · Cited by 23
Passariello, C., Nencioni, L., Sgarbanti, R., Ranieri, D., Torrisi, M. R., Ripa, S., Garaci, E., & Palamara, A. T. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.06.008 · Cited by 23
Shilo, N. R., & Quach, C. (2010) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2010.10.007 · Cited by 23
Influenza vaccines to control influenza-associated bacterial infection: where do we stand?
Christopoulou, I., Roose, K., Ibañez, L. I., & Saelens, X. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2015.957191 · Cited by 23
Tang, Y., Su, R., Gu, Q., Hu, Y., & Yang, H. (2022) · Antiviral Research · doi:10.1016/j.antiviral.2022.105502 · Cited by 22
DAMPs and influenza virus infection in ageing
Samy, R. P., & Lim, L. H. K. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.07.005 · Cited by 23
Pandemic A/H1N1v influenza 2009 in hospitalized children: a multicenter Belgian survey
Blumental, S., Huisman, E., Cornet, M., Ferreiro, C., Schutter, I. D., Reynders, M., Wybo, I., Kabamba, B., Armano, R., Hermans, D., et al. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-313 · Cited by 22
Linezolid Has Unique Immunomodulatory Effects in Post-Influenza Community Acquired MRSA Pneumonia
Bhan, U., Podsiad, A. B., Kovach, M. A., Ballinger, M. N., Keshamouni, V. G., & Standiford, T. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0114574 · Cited by 22
Diagnosis of Influenza from Respiratory Autopsy Tissues
Denison, A. M., Blau, D. M., Jost, H. A., Jones, T., Rollin, D., Gao, R., Liu, L., Bhatnagar, J., DeLeon-Carnes, M., Shieh, W., et al. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.09.004 · Cited by 22
Rotrosen, E. T., & Neuzil, K. M. (2017) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2017.03.007 · Cited by 22
Age-Related Pathology Associated with H1N1 A/California/07/2009 Influenza Virus Infection
Bissel, S. J., Carter, C. E., Wang, G., Johnson, S. K., Lashua, L. P., Kelvin, A. A., Wiley, C. A., Ghedin, E., & Ross, T. M. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.08.017 · Cited by 23
Stockman, J. A. (2010) · Yearbook of Pediatrics · doi:10.1016/s0084-3954(09)79450-3 · Cited by 22
Reducing inappropriate antibiotic use among children with influenza infection.
Friedman, B.-C., Schwabe-Warf, D., & Goldman, R. D. (2011) · PubMed · Cited by 21
Yu, K. O. A., Randolph, A. G., Agan, A. A., Yip, W., Truemper, E. J., Weiss, S. L., Ackerman, K. G., Schwarz, A. J., Giuliano, J. S., Hall, M. W., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw441 · Cited by 22
Obando, I., Valderrábanos, E. S., Millán, J., & Neth, O. (2010) · Archives of Disease in Childhood · doi:10.1136/adc.2009.175281 · Cited by 21
Antiviral Treatment of Influenza in Children
Garg, S., Fry, A. M., Patton, M. E., Fiore, A. E., & Finelli, L. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31824671ab · Cited by 19
Self-citationLiu, X., He, Y., Xiao, K., White, J. R., Fusco, D. N., & Papanicolaou, G. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057483 · Cited by 20
Bloes, D. A., Haasbach, E., Hartmayer, C., Hertlein, T., Klingel, K., Kretschmer, D., Planz, O., & Peschel, A. (2017) · Infection and Immunity · doi:10.1128/iai.00620-17 · Cited by 21
IL-10 Counteracts IFN-γ to Alleviate Acute Lung Injury in a Viral-Bacterial Superinfection Model
McKelvey, M. C., Uddin, M. B., Palani, S., Shao, S., & Sun, K. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2023-0437oc · Cited by 19
Clinical features of Malaysian children hospitalized with community-acquired seasonal influenza
Sam, I., Abdul-Murad, A., Karunakaran, R., Rampal, S., Chan, Y. F., Nathan, A. M., & Ariffin, H. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.10.005 · Cited by 19
Approach to Common Bacterial Infections
Tam, P. I. (2013) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2012.12.009 · Cited by 19
Mortality Predictive Scores for Community-Acquired Pneumonia in Children
Arbo, A., Lovera, D., & de Cuéllar, C. M. (2019) · Current Infectious Disease Reports · doi:10.1007/s11908-019-0666-9 · Cited by 19
Zheng, Y., He, Y., Deng, J., Lu, Z., Wei, J.-R., Yang, W., Tang, Z., Li, B., Zhang, J., Wang, L., et al. (2010) · Pediatric Pulmonology · doi:10.1002/ppul.21359 · Cited by 18
Estimated paediatric mortality associated with influenza virus infections, United States, 2003–2010
Wong, K. K., Cheng, P., Foppa, I., JAIN, S., Fry, A. M., & Finelli, L. (2014) · Epidemiology and Infection · doi:10.1017/s0950268814001198 · Cited by 18
Self-citationThe pharmacological management of severe influenza infection – ‘existing and emerging therapies’
McMahon, A., & Martín‐Loeches, I. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1255550 · Cited by 18
A Neonatal Murine Model of MRSA Pneumonia
Fitzpatrick, E. A., You, D., Shrestha, B., Siefker, D. T., Patel, V., Yadav, N., Jaligama, S., & Cormier, S. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169273 · Cited by 19
Khatri, A., Kraft, B. D., Tata, P. R., Randell, S. H., Piantadosi, C. A., & Pendergast, A. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816030116 · Cited by 18
Sex differences in susceptibility to influenza A virus infection depend on host genotype
Sabikunnahar, B., Lahue, K. G., Asarian, L., Fang, Q., McGill, M. M., Haynes, L., Teuscher, C., & Krementsov, D. N. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273050 · Cited by 18
Overview of Influenza Vaccines in Children
Lafond, K. E., Englund, J. A., Tam, J. S. L., & Bresee, J. (2013) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pit053 · Cited by 19
Self-citationJeannoël, M., Casalegno, J., Ottmann, M., Badiou, C., Dumitrescu, O., Lina, B., & Lina, G. (2018) · Toxins · doi:10.3390/toxins10070286 · Cited by 17
Kamata, K., Thein, K. N., Ja, L. D., Win, N. C., Win, S. M. K., Suzuki, Y., Ito, A., Osada, H., Chon, I., Phyu, W. W., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07342-1 · Cited by 19
Yang, M., Gao, H., Chen, J., Xu, X., Tang, L., Yang, Y., Liang, W., Yu, L., Sheng, J., & Li, L. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.10.018 · Cited by 17
Verma, A. K., McKelvey, M. C., Uddin, M. B., Palani, S., Niu, M., Bauer, C. D., Shao, S., & Sun, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1011132 · Cited by 18
Pulmonary bacterial coinfection in infants and children with viral respiratory infection
Thorburn, K., & Riordan, A. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.80 · Cited by 16
Klausberger, M., Ленева, И. А., Egorov, A., Strobl, F., Ghorbanpour, S. M., Falynskova, I. N., Поддубиков, А. В., Makhmudova, N. R., Krokhin, A., Свитич, О. А., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.10.083 · Cited by 16
Viral Infections in Children with Community-Acquired Pneumonia
Woods, C. R., & Bryant, K. A. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0324-6 · Cited by 16
Yoo, B., Humiston, S. G., Szilagyi, P. G., Schaffer, S. J., LONG, C. E., & Kolasa, M. (2015) · BMC Health Services Research · doi:10.1186/s12913-015-1169-5 · Cited by 15
de St. Maurice, A. M., Bridges, B. C., Rycus, P. T., Fonnesbeck, C. J., Fleming, G. M., & Halasa, N. B. (2016) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000000843 · Cited by 14
Ede, L. C., Loeffelholz, M. J., Alvarez-Fernandez, P., Pong, D. L., Patel, J. A., McCormick, D. P., & Chonmaitree, T. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31825f29db · Cited by 14
Hayashi, Y., Vaska, V. L., Baba, H., Nimmo, G. R., Davis, L., & Paterson, D. L. (2011) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2011.02602.x · Cited by 14
Dai, Z., Zhang, L., Yu, Q., Liu, L., Yang, M., & Fan, K. (2020) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002528 · Cited by 14
DeLeo, F. R., & Musser, J. M. (2010) · The Journal of Infectious Diseases · doi:10.1086/650304 · Cited by 14
Widdowson, M., & Monto, A. S. (2013) · doi:10.1002/9781118636817.ch16 · Cited by 14
Jalilian, B., Christiansen, S. H., Einarsson, H. B., Pirozyan, M. R., Petersen, E., & Vorup‐Jensen, T. (2013) · Molecular and Cellular Therapies · doi:10.1186/2052-8426-1-2 · Cited by 13
Fulminant Staphylococcal Infections
Gillet, Y., Henry, T., & Vandenesch, F. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0036-2018 · Cited by 13
Mikić, D., Nožić, D., Kojić, M., Popovic, S., Hristovic, D., Rajic-Dimitrijevic, R., Curcic, P., Milanović, M., Glavatovic, R., Begović-Kuprešanin, V., et al. (2011) · Vojnosanitetski pregled · doi:10.2298/vsp1103248m · Cited by 12
Metadata
- Authors
- Finelli, L., Fiore, A., Dhara, R., Brammer, L., Shay, D. K., Kamimoto, L., Fry, A., Hageman, J., Gorwitz, R., Bresee, J., & Uyeki, T.
- Affiliations
- National Center for Immunization and Respiratory Diseases (US)
- Centers for Disease Control and Prevention (US)
- Corresponding author
- Finelli, Lyn
- Venue
- PEDIATRICS
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2008-10-01
- Volume
- 122
- Issue
- 4
- Pages
- 805-811
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2032287546
- Cited by
- 312
- References
- 45
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 3 · 2023: 6 · 2022: 15 · 2021: 14 · 2020: 13 · 2019: 18 · 2018: 19 · 2017: 18 · 2016: 14 · 2015: 13 · 2014: 13 · 2013: 27 · 2012: 31
- FWCI
- 23.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Keywords
- methicillin-resistant Staphylococcus aureus, bacterial co-infection, influenza vaccination coverage, pneumonia, acute respiratory distress syndrome, influenza surveillance
- MeSH terms
- Adolescent, Child, Child, Preschool, Female, Follow-Up Studies, Humans, Infant, Infant, Newborn, Influenza, Human, Influenza Vaccines, Male, Prognosis, Retrospective Studies, Risk Factors, Staphylococcal Infections, Staphylococcus aureus, United States, Superinfection, Incidence, Survival Rate, Age Distribution, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
